Malignant disease, which can also be inherited from ancestors, is the third most common cause of death in men over the age of fifty in Hungary.
Semmelweis University (SE) is organizing a free prostate cancer screening and prevention day on November 10. Men aged 45-75 who have not yet been diagnosed with the disease but may be affected by their parents' prostate or breast cancer are invited to the screening day.
In a statement sent to MTI on Monday, the university wrote:
the chance of developing prostate cancer is twice as frequent in those who have had this disease in their family or have been diagnosed with a direct line of breast cancer. Malignant disease, which can also be inherited from ancestors, is the third most common cause of death in men over the age of fifty in Hungary.
The announcement quotes university professor Péter Nyirády, director of the SE's urology clinic, who says
it is a misconception that prostate cancer is only a disease of old men.
Younger patients, up to forty-five years old, are being met more and more often, and most of them have a genetic background, he said.
Screening is recommended every year or two from the age of fifty, or from the age of forty-five in case of family accumulation.
With the so-called PSA blood test, the level of prostate-specific antigen (PSA) is determined. Then there is a digital rectal examination, which is the inspection of the prostate through the rectum. This is a simple, painless, short procedure performed by a urologist, he explained.
Early-stage prostate cancer has few symptoms, or even no symptoms at all, if the disease is recognized at this time, the patient has a ninety percent chance of recovery.
Typical complaints include frequent, difficult or painful, sometimes bloody urine, or its retention, but these symptoms are not unique to prostate cancer. In this case, you should consult a doctor immediately to find out what could be behind it, they wrote.
They said:
on November 10, between 14:00 and 17:00, the screening at the urology clinic is free, but registration is required.
Applications for the prevention day are mainly expected from those who have had prostate or breast cancer on their parents' side. They can register online until 12 noon on November 9 or until the available test capacity is available. The application will be evaluated on the basis of medical criteria within two working days, and those who can participate in the screening will be notified by e-mail.
Those who are not invited will have the opportunity to attend a prostate exam at the clinic at a later date within two weeks.
The first part of the screening consists of a PSA blood test, the results of which are ready within two hours, then the manual examination is performed, which is essential for the results to be comprehensive.
Between examinations, the participants can listen to professional presentations and podium discussions about the treatment of prostate cancer, the possibilities of robotic surgery and the importance of prevention.
MTI
Photo: Pixabay
